hooglsw.blogg.se

Chlamydia medication
Chlamydia medication







chlamydia medication

Note: Should test results confirm an LGV infection, treat as recommended for LGV cases. Note: In pregnancy, use Erythromycin (non-estolate preparations) 500 mg PO QID for 21 days  Footnote 15 Sexual partners of a LGV case (empirical) LGV Preferred treatmentĭoxycycline 100 mg PO BID for 21 days  Footnote 15Īzithromycin 1g PO once weekly for 3 weeks  Footnote 16 Note: Suspected sexual abuse of children must be reported to the local child protection agency. Consider sexual abuse when a chlamydial infection is diagnosed in any prepubertal child.

chlamydia medication

trachomatis can persist for up to three years. Footnote 13Ĭonsult with a pediatric specialist or an experienced colleague and relevant clinical guidelines when chlamydia is diagnosed in a child.

  • Topical therapy for conjunctivitis is inadequate, systemic treatment is sufficient.
  • Equivalent dosages of other formulations may be substituted for erythromycin base.
  • Footnote 8 Footnote 9 Footnote 10 Footnote 11 Footnote 12
  • Erythromycin is associated with significantly higher gastrointestinal side effects than other treatment regimens.
  • Sulfamethoxazole 75 mg/kg/day PO in divided doses (max.
  • 500 mg QID for 7 days or 250 mg QID for 14 days)

    chlamydia medication

  • Erythromycin base 40 mg/kg/day PO in divided doses (max.
  • chlamydia medication

    1 g) PO in a single dose, if poor compliance is expected

  • Doxycycline 5 mg/kg/day PO in divided doses (max.
  • Nine (9) to 18 years of age Preferred treatment
  • Doxycycline and quinolones are contraindicated in pregnancy and in lactating women.
  • Estolate formulation is contraindicated in pregnancy.
  • Equivalent dosages of other formulations may be substituted.
  • Erythromycin dosage refers to the use of erythromycin base.
  • Footnote 3 Footnote 4 Footnote 5 Footnote 6 Footnote 7
  • Data are limited regarding the use of azithromycin in pregnancy, however many experts believe it has an acceptable risk-benefit profile.
  • Erythromycin 1g/day PO in divided doses for 14 days.
  • Erythromycin 2 g/day PO in divided doses for 7 days.
  • Note: Azithromycin may be preferred when poor compliance is anticipated.
  • Levofloxacin 500 mg PO once a day for 7 days Footnote 1.
  • Anogenital and conjunctival chlamydia Non-pregnant and non-lactating adults Preferred treatment Consult product monographs for contraindications and side effects.Ĭaution: Refer to the health advisory issued by Health Canada about azithromycin and risk of cardiovascular complications and death. The following treatment options are recommended in the absence of contraindication.
  • Suspected cases of LGV should be treated empirically while test results are pending.
  • Sexual partner of a suspected or confirmed case of LGV.
  • Suspected or confirmed LGV in people with proctitis, inguinal or femoral lymphadenopathy and/or buboes.
  • trachomatis infection or a compatible syndrome in a sexual partner. pelvic inflammatory disease, cervicitis, urethritis, conjunctivitis), without waiting for test results.
  • Suspected chlamydia in anyone presenting with a compatible syndrome (e.g.
  • gonorrhoea is done frequently by Nucleic Acid Amplification Tests (NAAT), which can provide results for both N. trachomatis due to high rates of co-infection. gonorrhoeae diagnosis (as empirical co-treatment), without waiting for test results of C.
  • National/provincial/territorial notification.
  • Sexual partners of a LGV case (empirical).
  • Treatment and follow-up of Chlamydia trachomatis infections (including lymphogranuloma venereum (LGV)).









    Chlamydia medication